Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion vs ESP Block in Bariatric Surgery
NCT05700214Completed
- Sponsor
- Jagiellonian University
- Start
- Feb 2023
- Primary completion
- Dec 2023
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Jagiellonian University. Primary endpoints: Total long acting opioid consumption in oxycodone equivalents at 1 day and Pain scores at 1 day. Started Feb 2023; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05700214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05700214.